使用具有成本效益的策略,在扩散的中线质瘤中发现新的EGFR突变:报告了2例病例
Iman Dandapath1, Saumya Sahu1, Supriya Bhardwaj1
1Neuropathology Laboratory, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.
Neuro-oncology practice
|May 13, 2024
概括
儿童的扩散性中线质瘤 (DMGs) 是一种具有攻击性的脑瘤. 这项研究在两个儿科DMG病例中发现了新的表皮生长因子受体 (EGFR) 突变,扩大了对瘤遗传学的理解.
科学领域:
- 儿科神经瘤学 儿童神经瘤学
- 癌症基因组学 癌症基因组学
- 分子病理学分子病理学
背景情况:
- 扩散性中线质瘤 (DMGs) 是具有不良预后的侵袭性儿科脑瘤.
- 2021年世界卫生组织分类定义了DMG亚型,基于H3K27三甲基化损失.
- 了解DMG分子复杂性对于改善诊断和治疗至关重要.
相关概念视频
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K